Analystreport

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald.

Madrigal Pharmaceuticals, Inc.  (MDGL) 
Last madrigal pharmaceuticals, inc. earnings: 2/26 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: madrigalpharma.com